Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Non-Current Deferred Tax Liability (2019 - 2021)

Legend Biotech filings provide 3 years of Non-Current Deferred Tax Liability readings, the most recent being $22.8 million for Q4 2021.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 35.05% to $22.8 million in Q4 2021 year-over-year; TTM through Dec 2021 was $22.8 million, a 35.05% decrease, with the full-year FY2021 number at $22.8 million, down 35.05% from a year prior.
  • Non-Current Deferred Tax Liability hit $22.8 million in Q4 2021 for Legend Biotech, down from $35.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $47.7 million in Q4 2019 to a low of $22.8 million in Q4 2021.
  • Median Non-Current Deferred Tax Liability over the past 3 years was $35.0 million (2020), compared with a mean of $35.2 million.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: decreased 26.54% in 2020 and later plummeted 35.05% in 2021.
  • Legend Biotech's Non-Current Deferred Tax Liability stood at $47.7 million in 2019, then decreased by 26.54% to $35.0 million in 2020, then plummeted by 35.05% to $22.8 million in 2021.
  • The last three reported values for Non-Current Deferred Tax Liability were $22.8 million (Q4 2021), $35.0 million (Q4 2020), and $47.7 million (Q4 2019) per Business Quant data.